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Results
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sequences showed a majority of infectious agents identified by pyrosequencing.
Conclusion
Conclusion: HIV patients with OSSN in Botswana are infected with a range of infectious agents which
may represent a unique microbiome. The persistent expressions of gene products by these agents some
of which are oncogenic are likely to contribute to the oncogenic process and suggest that treatment
modalities of the cancer should involve the screening for endemic agents.
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Abstract
Purpose: Ocular surface squamous neoplasia (OSSN) is a rare cancer previously seen in elderly men. In
Botswana there is an increase in OSSN and pterygia among young HIV-1 infected patients. Factors that
determine the course of this cancer have not been characterized. Recent studies identified HPV, EBV, KSHV,
HSV-1/2, and CMV in patient samples. We now characterize the microbiome associated with the disease that
may contribute to its course. Results: Pyrosequencing identified viruses, bacteria, fungus and parasites. Analysis
of shotgun cloning sequences showed a majority of infectious agents identified by pyrosequencing. Conclusion:
HIV patients with OSSN in Botswana are infected with a range of infectious agents which may represent a
unique microbiome. The persistent expressions of gene products by these agents some of which are oncogenic
are likely to contribute to the oncogenic process and suggest that treatment modalities of the cancer should
involve the screening for endemic agents.
Keywords: OSSN, pterygium, HIV-1, microbiome, shotgun cloning, pyrosequencing
1. Introduction
Ocular surface squamous neoplasia (OSSN) is a conjunctival or corneal neoplastic growth that encompasses the
conditions of simple dysplasia to conjunctival intraepithelial neoplasia (CIN) to invasive squamous cell
carcinoma (Kiire & Dhillon, 2006). Similar to cancer of the cervix, it has a relatively high rate of recurrence
after treatment and may metastasize (Munoz et al., 2003). OSSN has gained interest in the past few years in its
association with the HIV-1 pandemic and its increase in incidence is collinear with the increase in HIV-1
(Mahomed & Chetty, 2002). Prior to the HIV-1 pandemic, OSSN was noted to occur predominantly in the
elderly for whom it is the third most common oculoorbital tumor after melanoma and lymphoma (Basti &
Macsai, 2003; Lee & Hirst, 1997). Previously in addition to advanced age and male sex, other risk factors linked
to its pathogenesis had included ultraviolet light B rays and mutation of the p53 tumor suppressor gene (Kestelyn,
Stevens, Ndayambaje, Hanssens, & van de Perre, 1990), immunosuppression in organ transplant recipients
(Spitzer et al., 2008), cigarette smoking, and in some settings, HPV infection (Mahomed & Chetty, 2002;
McDonnell, McDonnell, Mounts, Wu, & Green, 1986). In Africa, OSSN is becoming more common, more
aggressive and affects mainly young people, especially females (Kestelyn et al., 1990).
In addition to OSSN and pterygia, some of the AIDS-related ocular lesions that are associated with viruses
include cytomegalovirus retinitis, conjunctival Kaposi's sarcoma, herpes zoster ophthalmicus, retinal
toxoplasmosis, choroidal Pneumocystis carinii infection, herpes simplex and herpes zoster retinitis, and
cryptococcal choroiditis (Verma & Kearney, 1996).
Schistosome parasites have been shown to be associated with cancer, and more specifically Schistosoma
hematobium can cause bladder cancer (Anastos, Hoover, Burk, et al., 2010). Chen and Mott observed that the
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endemicity of the parasite supports association of bladder cancer with schistosomiasis (Chen & Mott, 1989).
They also noted that the incidence of bladder cancer in the Middle East and Africa is greater in areas with higher
Schistoma prevalence and less in areas with lower prevalence (Chen & Mott, 1989). They noted that in tumor
cases the expression of p53, bcl-2, c-myc, and EGFR was higher in schistosomal bladder tumors (SBT) than in
non schistosomal bladder tumors (NSBT) while Rb was higher in NSBT than SBT, and that Cyclin D1 was
expressed in 57.5% of tumors, and was associated with schistosomiasis and early stage well differentiated
cancers (Anastos et al., 2010).
Fasciola hepatica (F.hepatica) also known as sheep liver fluke disease, is common in sheep and other domestic
livestock (Bunnag, Cross, & Bunnag, 2000). Human infection can occur from ingesting watercress in sheep
raising areas (Bunnag et al., 2000). The life span of adult F. hepatica is between 9 and 13 years. In addition to
hepatic parenchymal necrosis and abscess formation from migrating larvae, adult flukes cause hyperplasia,
thickening, desquamation and dilatation of the bile ducts (Bunnag et al., 2000). The oncogenic potential of F.
hepatica remains unproven at present, with a portion of the available evidence being contradictory. Experimental
data supports two opposite effects, that is, tumor growth stimulating and tumor growth inhibiting (Sriurairatana,
Tengchaisri, & Sirisinha, 1996).
Malaria has also been implicated in cancer. In a recent study Anastos et al. reported higher risk in CIN3+ HIV+
women in Rwanda who had recently acquired the malaria parasite (Anastos et al., 2010). Co-infection with
malaria in HIV-1 patients dysregulates the immune system (Bebell, Pilcher, Dorsey, et al., 2010). Bebell et al.
observed that acute HIV-1 infections occurred in high HIV prevalence regions of Uganda with low malaria
endemicity (Bebell et al., 2010). Kelly and Rickinson in their review of Burkitt’s lymphoma pathogenesis
emphasized the significance of HIV-1 and malaria (Kelly & Rickinson, 2007).
Though bacteria are the most abundant in the microbiome, not many of them have been associated with cancer.
However, studies now show a direct association of Helicobacter pylori with gastric adenocarcinoma (Lee &
Moss, 2007; Peek & Blaser, 2002; Blaser, Perez-Perez, Kleanthous, Cover, et al., 1995; Peek & Blaser, 2002),
and Bacteroides fragilis with colorectal carcinoma (Sears, 2009; Kim, Lee, & Kim, 2008). Additionally, fungal
toxins such as aflotoxins from Aspergillus flavus and Aspergillus parasiticus have been associated with liver
cancer (Kew, 2003).
These studies suggest the contribution of viruses, bacteria, fungi, and parasitic infections in initiation and
maintenance of these cancers. The identification of the known oncogenic viruses HPV, KSHV, and EBV in
OSSN and pterygia tissues suggests that they may contribute to the development of this malignancy in the HIV-1
infected population (Simbiri, Murakami, Feldman, et al., 2010). The aim of this study was to obtain a more
comprehensive identification of the associated microbiome in patients with OSSN in the HIV-1 infected
population in Botswana. The significance of microbes in cancer initiation and maintenance cannot be
emphasized enough when the many processes they can influence are considered (Table 1).
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Table 1. Microbial processes associated with cancer initiation
Mechanism

Microbe

Cancer

Reference

DNA repair

H.pylori

Gastric adenocarcinoma

PlOS Pathogens (2010) 6 (7)

S.mansoni

Colorectal carcinoma

Int J Colorectal Dis (2007) 22:175–181

O.viverrini

Cholangiocarcinoma

Parasit Intern.(2012) 61:130-135

H.pylori

Gastric adenocarcinoma

Expert Opin Ther Targets (2007):11(6)757-769

S.bovis

Colorectal carcinoma

Carcinogenesis(2004)25(8):1477-84

S.haematobium

Bladder cancer

Mutat Res. (1994) 305:283-292

O.viverrini

Cholangiocarcinoma

Int. J. Cancer (1991), 48:821-825

B.fragilis

Colorectal carcinoma

Clin Microbiol Rev. 2009 Apr;22(2):349-69

S.bovis

Colorectal carcinoma

Carcinogenesis(2004)25(8):1477-84

B.fragilis

Colorectal carcinoma

Eur. J. Immunol. 2008. 38: 2190–2199

S.haematobium

Bladder cancer

Cancer Res. 1994 Apr 1;54(7 Suppl):1929s-1933s

H.pylori

Stomach

Nat Rev Cancer 2002;2:28–37

A flavus

Liver carcinoma

Liver International (2003)23 (6):405-409

S.haematobium

Bladder cancer

Cancer Res. 1994 Apr 1;54(7 Suppl):1929s-1933s

H.pylori

Gastric adenocarcinoma

Carcinogenesis(2004)25(8):1477-84

H.pylori

Gastric adenocarcinoma

Cancer Res 1995;55:2111–5

S.bovis

Colorectal carcinoma

Carcinogenesis(2004)25(8):1477-84

B.fragilis

Colorectal carcinoma

Clin Microbiol Rev. 2009 Apr;22(2):349-69

C. sinensis

Liver carcinoma

Parasit Intern.(2012) 61:130-135

C. sinensis

Liver carcinoma

Parasit Intern.(2012) 61:130-135

H.pylori

Gastric adenocarcinoma

Nat Rev Cancer 2002;2:28–37

O.viverrini

Cholangiocarcinoma

Int.J. Cancer (1991), 48:821-825

S.aureas

SCC Skin

Cancer Epidemiol Biomarkers Prev. (2009) 18(2)
472-478

H.pylori

Gastric adenocarcinoma

Nat Rev Cancer 2002;2:28–37

S.haematobium

Bladder cancer

Experimental Parasitology(2009)130:(2)250-253

B.fragilis

Colorectal carcinoma

Clin Microbiol Rev. 2009 Apr;22(2):349-69

Proliferation

Apoptosis
Differentiation
Carcinogen
metabolism

Inflammation

Immune function

Hormonal
regulation

The table shows pathogens that have been identified with the development of specific human cancers and the
mechanistic processes associated with each of the cancers
2. Research Methods
2.1 Patient Samples
HIV-1 infected patients with conjunctival lesions seen at Princess Marina Hospital, Gaborone, Botswana from
April 11 2007 to April 14 2008 were enrolled in this study (IRB #805049 and Ministry of Health, Botswana REF
NO: PPME 13/18/1 Vol III 141). All patient diagnosis and enrollment were as described previously (Simbiri et
al., 2010). Briefly, patients were identified by an ophthalmologist in the tertiary care ophthalmology clinic at
Princess Marina Hospital which serves as the referral center for southern Botswana. All HIV-1 positive patients
diagnosed using a HIV-ELISA (Abbott Laboratories, Hoofddorp, the Netherlands) with clinical features
suggestive of OSSN or pterygium were enrolled the day before surgery. Written consent was obtained from each
subject in either Setswana or English (according to subject’s preference). Tissue specimens obtained in the
ophthalmology operating room were divided into two pieces by the ophthalmology surgeon - one piece was sent
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for histopathologic analysis and the other was immediately placed in tissue transport medium for shipment to the
University of Pennsylvania viral oncology laboratory. Histologic confirmation of each clinical diagnosis was
obtained from the Botswana National Health Laboratory’s histo-pathologist. 39 patients participated in the study,
however tissue samples of varying sizes were obtained from only 36 cases. Tissues from patients included in this
study were 30 whose clinical diagnosis was OSSN and 9 with pterygia (Table 2). The research was approved by
the University of Pennsylvania ethics committee and adhered to the tenets of the Declaration of Helsinki. Tissue
specimens were analyzed by histopathology to determine the stage of the cancer and also further analyzed for
identification of the associated infectious agents. Histological confirmation of clinical diagnosis was determined
by the University of Pennsylvania resident pathologist.
Table 2. Patient Characteristics
Case #

OSSN
#

Pterygia
%

#

%

P-value

Odds Ratio

Total

30

(77)

9

(23)

0.79

Males

11

(37)

2

(22)

0.63

1.6

Females

19

(63)

7

(77)

0.58

0.81

Viral load <400

13

(43)

3

(33)

0.56

1.3

Viral load >400

07

(100)

0

(0)

0.05

7.0

Viral load ND

10

(33)

4

(44)

0.47

0.73

CD4<200

18

(60)

2

(22)

0.29

2.7

CD4>200

07

(23)

6

(67)

0.91

0.3

CD4 ND

05

(17)

1

(11)

0.79

1.45

ART

19

(63)

5

(56)

0.67

1.14

ART ND

11

(37)

4

(44)

0.69

0.81

The table shows patient diagnosis, sex, CD4 counts, viral load, and the retroviral therapy (ART) status of each
patient on enrollment. Patients were diagnosed as OSSN or Pterygia clinically and by histology. There were
more OSSN with viral load >400 copies/ml, and more pterygia with CD4 counts >200 cells/μl. Because of the
low number of subjects the P-values based on Fisher’s test did not reach significance level except for viral
load >400copies/ml in which all were OSSN. However, OR from the table shows that males, subjects with viral
load <400, subjects with viral load >400, subjects with CD4<200, and subjects under Antiretroviral (ART) are
more likely to be OSSN than pterygia.
2.2 Pyrosequencing
Sera samples were prepared using Whole Genome Amplification Procedure based on Qiagen REPLI-g Midi kit
150043 (Qiagen, Valencia, CA): 200μl of serum were spun down at 6000xg for 10 min and supernatant
discarded. Pellet was resuspended by adding 50µl TE and vortexing for 5seconds. 10µl denaturation buffer was
added to the tubes and mixed 3X by pipetting and setting on ice for 10 minutes. 10µl Stop Solution was added to
each tube containing the lysed cells and mixed by pipetting 3X. Master mix was prepared by mixing 10µl
nuclease free water, 29µl REPLI-g Midi reaction buffer, 1µl Repli G Midi DNA polymerase (40µl) and added to
each sample.
The samples were incubated at 300C overnight at 650C for 3 minutes then stored at -200C until use. 10µl was sent
for pyrosequencing using 454 (454 Life Sciences, Branford, CT) pyrosequencing technique for global detection
of foreign sequences expressed in OSSN and pterygia samples.
2.3 Shotgun Cloning of DNA Extracted from Patient Sera
We extracted DNA from sera, purified, and then digested with BamH1 restriction enzyme. Briefly, 500μl serum
was aliquoted into eppendorf tubes and spun at maximum speed of 15,000 rpms at 4°C for 30 minutes. The
aqueous layer was transferred into new tubes and frozen at -80°C for 1hour to overnight. The pellet was
resuspended with 250μl of 0.2x PBS. 5μl DNAse and 5μl RNAse was added (from stock of 5mg/ml) and
incubated at 370C for 1-2 hours. 5μl proteinase-K was added (10mg/ml stock) and incubated for 20 minutes at
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56°C. The samples were further incubated at 96°C for 10minutes. 5μl Proteinase-K was added and incubated for
1hour at 56°C. The samples were incubated at 96°C for 30 minutes and volume brought to 500μl with 0.2X PBS.
Using buffered phenol with Tris pH7.5 1:1, samples were extracted 2X and spun at maximum speed at RT for 5
minutes. The aqueous layer was transferred into new tubes, and an equal volume of chloroform added and mixed.
The samples were spun at maximum speed at RT for 5 minutes and transferred to new tubes. 50μl sodium acetate
(3M) was added and an additional 1ml absolute ethanol was added and incubated o/n at -20°C. The samples were
spun at 4°C maximum speed for 15minutes and aspirated with drawn out Pasteur pipette. The samples were
washed 2X with 1ml 70% ethanol by spinning at maximum speed for 5 minutes at RT. The supernatant was
aspirated, air dried and dissolved in 30μl TE. 10μl of the samples were digested with BamH1 restriction enzyme
for 3 hours, run on 0.8% Agarose gel. The bands were extracted, purified and ligated into pBluescript vector
(Agilent Technologies, Santa Clara, CA). Some clones were picked, purified in 0.8% agarose gel and sequenced.
3. Analysis Result
3.1 Sequencing of Nucleic Acids from Patient Sera Shows the Presence of Sequences Which Identifies Parasites,
Bacteria, Viruses, and Fungi Endemic in Sub-Sahara Region
Table 3. Infectious agents identified in sera samples of patients by shotgun cloning
VIRUSES

BACTERIA

PARASITES

FUNGI

RNA viruses

Gram negative

Nematodes

Schizosaccharomyces
pombe

HIV-1

Klebsiella spp

Dirofilaria immitis

Sordariomyceta
sordariaceae

Rous sarcoma virus(RSV)

Pseudomonas spp*

Oncocerca volvulus

Agaricales marasmiaceae

Dengue virus type 3

Salmonella spp*

Trichinella spiralis

Eurotiomycetes
neosartorya

Influenza A

Neisseria gonorhoea

C. elegans

Tremallaceae
filobasidiella

Human respiratory syncytial
virus

E. coli spp*

Trematodes

DNA viruses

Vibrio spp*

Nemertoderma spp*

Equine herpes virus type 1

Gram positive

Sterreria spp*

HHV-4

Staphylococcus aureas

Schmidtea polychroa

HHV-5

Mycobacterium spp*

Fasciola hepatica

HHV-6

Clostridium spp*

Protozoa

HHV-8

Streptococcus spp*

Plasmodium. falciprum

SV-40

Leishmania. chagasi
Trypanosoma spp*
Cryptosporadium
hominis
Parasitic vectors
Glossina palpalis
Culex spp*

*More than one species detected in samples
Utilizing shotgun cloning method 500μl serum from patients was aliquoted into eppendorf tubes. The samples
were spun down at maximum speed for 30 min at 40C. The pellets were resuspended with 250μl 0.2X PBS. 5μl
DNAse and RNAse (5mg/ml stock) were added to each sample and incubated for 1-2 hours. 5μl of proteinase K
(10mg/ml stock) was added and incubated for 20min at 56°C. Samples were further incubated at 96°C for 10
min. 5μl proteinase K was again added and incubated for 1 hr at 56°C followed by denaturation at 96°C for 30
min. The volume was brought to 500μl with 0.2X PBS. The samples were extracted 2X using buffered phenol
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with Tris pH 7.5 1:1. Samples were spun down at maximum speed at RT for 5 mins and aqueous layer
transferred into new tubes into which equal volume of chloroform was added and mixed well. Samples were
spun down again and transferred into new tubes and 50μl (3M) sodium acetate added. 1ml absolute ethanol was
added and samples were incubated at -200C overnight. The next day samples were spun down at maximum speed
at 40C. Ethanol was decanted and 70% ethanol added and samples spun at maximum speed for 5 min at RT. The
supernatant was aspirated and samples were air dried and dissolved in 30μl TE. We prepared pBluescript vector
and patient samples by digesting with BamH1. The inserts were ligated into the vector by using T4 ligase and
incubated overnight at 160C. Products were used to transform DH5α competent cells and plated on ampicillin
resistant plates overnight. Colonies were selected and DNA was extracted, purified and digested with BamH1 to
confirm inserts. The samples were then sent for sequencing. RNA viral, DNA viral, bacterial, parasitic and
fungal sequences were identified in the samples. There were more herpestype viral sequences among the
identified viruses and more bacterial sequences than all identified pathogenic sequences put together. Fewer
fungal sequences were observed.
We cloned DNA from sera samples from patients with OSSN and pterygia. The results showed that the samples
contained sequences from a wide range of bacteria, viruses, parasites, and fungi (Table 3). We also detected
parasitic vector sequences such as Glossina palpalis and Culex quinquuefasciatus in the samples. The direct
association and contribution of some of the parasites and the vector moieties to the overall pathology of the
cancer is not known. Interestingly, we observed a greater number of herpes type viruses that have been
associated with oncogenesis (McDonnell, 1986; Simbiri et al., 2010; Hoshikawa, Satoh, Murakami, et al. 2002),
and bacteria, parasites, and fungi whose co-infection leads to enhanced immunosuppression of the HIV infected
host (Lloyd-Smith, Poss, & Grenfell, 2008; Barnabas, Webb, Weiss, & Wasserheit, 2011). Fungal S. pombe and
the common free living soil nematode C.elegans were also detected. Thus the implication of identifying both
parasite and vector, viral, bacterial and fungal sequences in these samples is far reaching in regards to
immunosuppression, which may result from this onslaught from multiple infectious agents on the
immunocompromised HIV-1 patients.
3.2 A Greater Number of Infectious Pathogens are Present in OSSN Patients than in Pterygia Patients Infected
with HIV-1
Pyrosequencing of DNA from sera obtained from OSSN and pterygia subjects indicated that patients had been
exposed to different infectious agents that may contribute to the pathogenesis of OSSN. Additionally, there were
more sequences of bacteria, followed by viruses, and parasites in patients. A majority of the identified pathogenic
sequences were higher in the OSSN than pterygium samples (Figure 1, 2, 3).
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Escherichia coli
Kleb. Pneu subsp.pneu MGH 78578
Salmonella enterica Typhimurium
Escherichia sp.Sflu5
Escherichia coli 026:H Haem ophilus influenzae 86 -028NP
Escherichia fergusonii ATCC 35469
Salmonella enterica serovar Dublin
Erwinia amylovora
Acinetobacter baum annii AB0057
Salm onella enterica Typhi str. CT18
Neisseria gonorrhoeae
Enterobacter cloacae
Salm onella enterica Heidelberg str.SL476
Salm onella enterica Choleraesuis
Pseudomonas aeruginosa
Citrobacter freundii
Salmonella enterica Schwarzengrund str. CMV:
Staphylococcus aureus
Haemophilus influenzae
Klebsiella pneum oniae
Salm onella enterica Choleraesuis str. SC -B67
Pseudom onas aeruginosa PA7
Escherichia coli 0111:H -str. 11128
Escherichia coli 1520
Rhodopseudom onas palustris TIE -1
Providencia rettgeri
Escherichia coli SMS -3-5
Acinetobacter baumannii AYE
Acinetobacter calcoaceticus
Acinetobacter baumannii AB307 -0294
Acinetobacter baum annii ATCC 17978
Acinetobacter sp. ADP1
Acinetobacter baumannii ACICU
Acinetobacter sp.SUN
Acinetobacter baumannii AYE
Acinetobacter baum annii SDF
Acinetobacter venetianus
Heliobacterium modesticuldum Ice1
Escherichia coli 055:H7 str. CB9615
Shigella flexneri 2a
Escherichia coli SE11
Escherichia coli 0157:H7 str. EC4115
Escherichia coli APEC 01
Escherichia coli 0157:H7 str.TW14359
Escherichia coli 0157:H7 str.11368
Escherichia coli 536
Escherichia coli E24377A
Escherichia coli 0157:H7 str. EDL933
Escherichia coli 0157:H7 str. Sakai
Escherichia coli UMN026
Bifidobacterium anim alis Lactis AD011
Citrobacter koseri ATCC BAA -895
Salmonella enterica serovar Enteritidis
Pseudomonas aeruginosa fulva
Escherichia coli SE11
Shigella sonnei Ss046

Pterygium
OSSN

0

5000

10000

15000

20000

25000

30000

35000

Num ber of Reads

Figure 1. Representative bacterial sequence identified in patient sera
The figure shows the composition of the bacteria identified showing significant number of the bacteria, their
species and sub-species in OSSN cases having more sequences and higher reads than pterygia. We also noted
that OSSN case had extra E.coli subspecies not detected in pterygium, while pterygium had additional
Acinobacter baumannii subspecies missing in OSSN
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Figure 2. Representative viral sequences identified in patient sera
There were more virus reads for OSSN than pterygia. We observed higher reads for Avian carcinoma virus,
HIV-1, SIV, SV-40, Enterobacteria phage M13, and Y73 sarcoma virus than in pterygium.

Figure 3. Representative parasite sequences identified in parasite sera
There were more parasite reads for OSSN than pterygia. Specifically we noted higher counts of Schmidtea
polychroa, Schistosoma japonicum, and Schistosoma mansoni.
Samples were prepared using Whole Genome Amplification Procedure based on Qiagen REPLI-g Midi kit
150043(Qiagen): 200µl of serum were spun down at 6000xg for 10 min and supernatant discarded. Pellet was
resuspended by adding 50µl TE and vortexing for 5sec. 10µl denaturation buffer was added to the tubes and
mixed 3X by pipetting and setting on ice for 10 min. 10µl Stop Solution was added to each tube containing the
lysed cells and mixed by pipetting 3X. Master mix was prepared by mixing 10µl nuclease free water, 29µl
REPLI-g Midi reaction buffer, 1µl Repli GMidi DNA polymerase (40µl) and added to each sample. The samples
were incubated at 300C overnight. The polymerase in the samples was inactivated by heating at 65oC for 3 min
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then storing at -200C until use. 10µl was sent for pyrosequencing using 454 (454 Life Sciences, Branford, CT)
pyrosequencing technique for global detection of foreign sequences expressed in OSSN and pterygia samples.
The sequencer uses parallel pyrosequencing technique to generate about a million bases in 7.5hrs run with a read
of about 250 bases. The uniqueness of this application is that it includes de novo whole genome sequencing
supported by paired-end mapping, amplicon resequencing, transcriptome analysis that greatly enhanced
detection of foreign sequences in our samples. Using this technique we were able to detect viruses, bacteria,
fungi, and parasites.
Of interest was the detection of more gram-negative bacteria compared to gram positive bacteria, specifically
those that were present in both OSSN and pterygia, but higher in OSSN than pterygia. Notable were gram
negative Neisseria gonorrhea a common sexually transmitted bacteria, and the ubiquitous gram positive
nosocomial agent Staphylococcus aureus. Of significance was the observation of several different subspecies of
E.coli in OSSN alone and similarly several different subspecies of Acinobacter baumannii in pterygia alone
(Figure 1). Of the viruses we were surprised at the level of Avian carcinoma virus, Enterobacteria phage M13,
and Y73 sarcoma virus (Figure 2). The parasitic sequences (Figure 3) were interesting because previous studies
suggest that some which include S. mansoni and F. hepatica, have been associated with cancer (Chen & Mott,
1989; Bunnag et al., 2000; Sriurairatana et al., 1996).
Furthermore, OSSN patient who was more immunosuppressed generated a much higher level of infectious
agents compared to pterygium patient. Interestingly, there were about a 5-10 fold greater increase in the load of
bacteria, parasites and viruses seen in OSSN sample compared to pterygia sample (Figure 1, 2, 3).
4. Discussion
Our study of OSSN tissues from Botswana HIV-1 infected patients has led to significant findings, namely the
association of multiple oncogenic viruses with this cancer (Simbiri et al., 2010). In the current study through
cloning and pyrosequencing, our results showed sequences of additional viruses, bacteria, fungi, and parasites in
the sera of the patients. There is an increasing amount of investigation examining the modifying effect on host
susceptibility that one pathogen has on another. Thus many bacterial, viral, and protozoal infections induce
protective Th1 cell-mediated immune response in resistant individuals while helminth infections lead to
predominantly Th2 skewing of the immune effector cells (Yang, Gray, Ellis, Yang, Craig, McManus, 2009), yet
with findings such as ours, little has been done to determine these associations and their effects on the individual
and the general exposed population.
To our knowledge this is the first report which demonstrates the co-existence of a significant number of bacteria,
viruses, parasites, and fungi in OSSN and pterygia patient samples. Pyrosequencing of DNA extracted from sera
of patient samples confirmed early findings based on cloning and sequencing of similar samples, showing that
the patients were exposed to many bacteria, viruses, and parasites (by new infections or reactivation of dormant/
latent infections) (Lloyd-Smith et al., 2008), infections that could exacerbate the existing immunocompromised
conditions. From our representative samples, it was noted that OSSN patient with CD4 counts of 134 cells/µl
and viral load of 120,000 copies /ml was more immunosuppressed having more bacterial, viral and parasitic
infections than pterygium patient with CD4 counts of 293 cells/µl and viral load of <400 copies /ml. The skewed
count of E.coli subspecies in OSSN and Acinobacter baumannii subspecies in pterygia may suggest some
microenvironmental changes due to stage of the disease and specific microbiota load influencing the growth of
these specific bacteria in the specific subjects. These results build support for multiple infection with other
agents leading to severe immunosupression from low CD4 cell counts, and chronic stimulation that in addition
could lead to tolerance and suppression of the expression of cytokines to lower levels than HIV-negative and
OSSN-negative control drawn from the same region. The depletion of CD4+/CD8+ cells and dysfunction of CD8+
cells that play critical roles in defense against most pathogens, including viruses, and can lead to activation of
herpesviruses which are usually latent (Griffin, Krantz, Selke, Huang, & Wald, 2008; Whitley, Kern, Chatterjee,
Chou, & Roizman, 1993) may play a significant role during the pathogenesis of the disease in these patients. The
possibility that oncogenic proteins or immunosuppressive factors from these infectious agents contribute to
OSSN pathology is thus suggested. Indirectly infectious agents may contribute to cancer by increasing HIV-1
viral load that leads to more immunosupression thus enhancing oncogenesis and an increase in opportunistic
infections (Palefsky, 2009). Barnabas et al reported an increase in HIV-1 viral load with malaria, HSV-2, and
tuberculosis infections (Barnabas, Webb, Weiss, & Wasserheit, 2011). Thus, it is possible that if we have
immunocompromised patients who are susceptible and infectious then transmissibility of the infectious agents
can be increased to a level that a strain that would die out in HIV-1 negative individual will be able to
successfully invade potential hosts and persist. Though our patient cohort was under Antiretroviral Therapy
(ART) started at different time points, their effects with regards to these infectious agents that also cause
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immunosupression and some cancers has not been evaluated. It is possible that before ART era AIDS patients
died before the appearance of HPV and other HIV associated lesions, and that the prolongation of life now
allows the development of these benign and neoplastic lesions (Meys, Gotch, & Bunker, 2010). There are studies
that show that the success of ARTs lowering HIV-1 viral load leads to increased opportunistic infections, some of
which are drug resistant (Palefsky, 2009; Croft, Sundar, & Fairlamb, 2006; Legros, Evans, Maiso, Enyaru, &
Mbulamberi, 1999).
Herrera and Ostrosky-Wegman noted that chronic inflammation in host tissues is a common feature of helminth
infections (Herrera & Ostrosky-Wegman, 2001). The longer the inflammation persists, the higher the risk of
associated carcinogenesis. Some of our patients showed increased levels of inflammatory cytokines and growth
factors that support Herrera’s findings (unpublished data). However, in the experiments we observed decreased
expression of several inflammatory cytokines, a factor possibly resulting from the global immunosupression by
these infectious agents in an already immunocompromised patient. Some studies have shown that HIV Tat is
able to penetrate the intact stratified epithelium of the cornea and wounded cornea, allowing rapid and intense
penetration of Tat into the deeper stratified epithelium and stromal tissue (Guo, Hutcheon, & Zieske, 2004). Thus,
the secretion of HIV Tat may lead to its penetration of mucosal epithelial cells leading to activation of NF-kB.
HIV-Tat mediated activation of NF-kB may activate latent herpesviruses because most herpesviral promoters
have response elements to NF-kB (Santoro, Rossi, & Amici, 2003). Activation of NF-kB may also lead to the
upregulation of HPV oncoproteins, facilitating the progression of HPV neoplastic processes (Ruutu, Peitsaro,
Johansson, & Syrjanen, 2002).
Furthermore, disruption of the corneal epithelium may lead to superinfection with new strains of the viruses thus
enhancing oncogenesis (Remeijer, Maertzdorf, Buitenwerf, Osterhaus, & Verjans, 2002). The opportunistic
viruses which we identified in our samples may also activate HIV replication by interacting with the HIV-1
transcription machinery. Herpesvirus immediate early proteins transactivate HIV-1 long terminal repeat (LTR)
facilitating HIV replication. HSV-1 immediate early proteins ICP0, ICP4, ICP27, and transactivating proteins
IE110 and IE175 induce transactivation of HIV-1 LTR by upregulating NF-kB (Margolis, Rabson, Straus, &
Ostrove, 1992), while EBV EBNA-2 may transactivate HIV-1 LTR in synergy with HIV-1 Tat (Zhang, Guan,
Park, et al., 1997), and HHV-8 LANA can also activate HIV LTR (Hyun, Subramanian, Cotter, Thomas, &
Robertson, 2001). Elucidation of the interaction of these factors from the viruses identified in the samples and
their impact in OSSN pathogenesis will enhance our knowledge of the molecular processes involved that may
lead to the design of therapeutic molecules to block the activated pathways.
Raziuddin et al. found that TNF-α levels are greatly elevated in patients with S. haematobium-induced squamous
cell bladder cancer (Raziuddin, Masihuzzaman, Shetty, & Ibrahim, 1993). Recurrent bacterial urinary tract
infections are known to be associated with squamous cell carcinomas of the bladder, even in the absence of
concomitant S. haematobium infection (Badawi, 1996). El-Hawey et al. found that 39–66% of hospitalized
patients with schistosomiasis had urinary tract bacterial infections (el Hawey, Massoud, Badr el Din, Waheeb, &
Abd-el Hamid, 1989). Mostafa et al. isolated nitrate-reducing bacteria such as Staphylococcus aureus,
Staphylococcus albus, Proteus mirabilis, Klebsiella species and Escherichia coli, from urine samples of S.
haematobium-infected patients (Mostafa, Helmi, Badawi, Tricker, Spiegelhalder, & Preussmann, 1994). Habuchi
et al. found that 86% of Egyptian patients with schistosome-associated bladder cancer had p53 mutations in
exons 5, 6, 8 and 10 (Habuchi, Takahashi, Yamada, et al., 1993). Badawi noted that as tumor grade increased, so
did the p53 mutation rate (Badawi, 1996). Lozano et al. reported that nitric oxide produced by the inflammation
from schistosomal egg deposition could cause
p53 mutations through stimulation of endogenous N-nitroso compound generation resulting in DNA alkylation
(Lozano, Nakazawa, Cros, Cabral, & Yamasaki, 1994). We confirmed S. mansoni sequences in our samples, and
their contribution to OSSN pathogenesis along with the other infectious agents is intriguing. Studies have shown
that acute schistosomiasis increased risk of AIDS virus acquisition possibly through Th2 type immunologic
phenotype and increased viral replication in these cells as shown in Kenyan schistosomiasis patients with HIV-1
coinfection producing decreased levels of IL-4 and IL-10 compared to patients with schistosomiasis alone
(Mwinzi, Karanja, Colley, Orago, & Secor, 2001). However, we are not able to predict that the viral and bacterial
interactions observed in S. mansoni infections and p53 mutations contributed to OSSN pathogenesis in our
cohort.
Malaria whose sequences were also confirmed has been associated with HIV-1 infection and incidence of
symptomatic episodes which may be severe or uncomplicated and the corresponding parasite density has been
reported to be higher in HIV-1 infected individuals with low CD4 counts (Korenromp, Williams, de Vlas, et al.,
2005). Some studies have shown increased viral load with acute malaria and decreased viral load following
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treatment (Barnabas et al., 2011).
Mycobacterium tuberculosis one of the many bacteria whose sequences we identified has been defined as a
syndemic (convergence of two or more diseases that act synergistically to magnify the burden of disease) with
HIV-1 (Kwan & Ernst, 2011). HIV-1 causes the depletion of CD4 T cells contributing to susceptibility of
coinfected individuals to TB, as this T cell subset is significant in the control of TB and a majority of HIV-1
infected individuals are now coinfected with TB (Diedrich & Flynn, 2011).
5. Conclusion
Our studies identified sequences from many bacteria, viruses, parasites and fungi in OSSN and pterygia from the
HIV-1 infected population suggesting that multiple pathogenic agents may have a role in development of this
disease. The interaction between different pathogenic agents and the dysregulatory activities of oncogenic
moieties and other antigenic factors in immunocompromised individuals may contribute to oncogenic
transformation. The processes, pathways, and levels of interaction of the different pathogen oncogenic moieties
in initiating oncogenesis require further studies. Clearly, there is a need to elucidate the molecular processes and
pathways involved in pathogenesis of OSSN and pterygia in the HIV population that may lead to development of
therapies to control and prevent the diseases. In the Botswana population, it is possible that co infections, the
minimal use of parasitic drugs, the innate ability of rapidly evolving organisms to attain resistance to commonly
used therapy and the suppression of cell mediated immunity that occurs with AIDS has led to an increase in
many common infectious diseases that often act in synergy and may have contributed to the initiation and
increased pathogenesis of OSSN.
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